ABOUT THE SERVICE
Rafael Holdings’ investment in Cyclo Therapeutics provides access to a pipeline of novel cancer therapies, specifically focused on Niemann Pick Type C1. This represents a significant opportunity to deliver a breakthrough treatment option for patients with this challenging disease.
Information is owner-confirmed
Last updated 5 months ago
Price range
Other products/services from Rafael Holdings, Inc.
Oncological Therapeutics
Biotechnology
N/A
Rafael Holdings, Inc.
United States (US)